The new strategy enables us to detect putative pathogenic variants throughout the genome and can differentiate specific variants of IKBKG from IKBKGP1. Thus, the strategy proposed here is able to overcome pseudogene-related complications in IP detection. This evidence concerns the gene IKBKGP1 and incontinentia pigmenti.